HBW
CVS icon

Hazlett, Burt & Watson’s CVS Health CVS Stock Holding History

Hazlett, Burt & Watson’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
1,537
-298
-16% -$26.6K 0.04% 299
2026
Q1 		$131K Buy
1,835
+306
+20% +$23.6K 0.04% 305
2025
Q4 		$120K Buy
1,529
+342
+29% +$27K 0.04% 319
2025
Q3 		$89K Sell
1,187
-495
-29% -$33.9K 0.03% 330
2025
Q2 		$117K Buy
1,682
+165
+11% +$10.8K 0.05% 258
2025
Q1 		$103K Sell
1,517
-410
-21% -$24.5K 0.05% 272
2024
Q4 		$86K Sell
1,927
-648
-25% -$36.4K 0.04% 293
2024
Q3 		$163K Buy
2,575
+229
+10% +$13.4K 0.08% 225
2024
Q2 		$139K Sell
2,346
-2,401
-51% -$150K 0.07% 225
2024
Q1 		$379K Sell
4,747
-359
-7% -$27.4K 0.23% 95
2023
Q4 		$403K Sell
5,106
-683
-12% -$48.6K 0.27% 73
2023
Q3 		$403K Sell
5,789
-3,170
-35% -$225K 0.3% 69
2023
Q2 		$620K Buy
8,959
+406
+5% +$28.9K 0.46% 39
2023
Q1 		$635K Buy
8,553
+763
+10% +$64K 0.52% 34
2022
Q4 		$727K Sell
7,790
-308
-4% -$29.7K 0.64% 30
2022
Q3 		$773K Buy
8,098
+22
+0.3% +$2.18K 0.75% 26
2022
Q2 		$750K Sell
8,076
-23
-0.3% -$2.25K 0.69% 30
2022
Q1 		$819K Buy
+8,099
New +$851K 0.65% 32

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hazlett, Burt & Watson's CVS Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its CVS Health (CVS) stake by 16% in Q2 2026, selling an estimated $26.6K and leaving 1,537 shares worth $160K. The position accounts for 0.04% of the portfolio, ranked #299.

Hazlett, Burt & Watson first reported a position in CVS in Q1 2022 and has held it in 18 quarters since. The position peaked at $819K in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Hazlett, Burt & Watson held 1,537 shares of CVS Health worth $160K as of Q2 2026.
  • Hazlett, Burt & Watson sold 298 CVS Health shares in Q2 2026, an estimated $26.6K.
  • CVS Health made up 0.04% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #299 holding.
  • Hazlett, Burt & Watson first reported a position in CVS Health in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's CVS Health position peaked at $819K in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.